Cognition and beta-amyloid in preclinical Alzheimer's disease: Data from the AIBL study
Kerryn E Pike, Kathryn A Ellis, Victor L Villemagne, Norm Good, Gael Chetelat, David Ames, Cassandra Szoeke, Simon M Laws, Giuseppe Verdile, Ralph N Martins, Colin L Masters, Christopher C Rowe
Neuropsychologia | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2011
Core funding for the study was provided by the Australian Commonwealth Scientific Industrial Research Organization (CSIRO) through the Australian Imaging, Biomarkers and Lifestyle flagship study of aging (AIBL), which was supplemented by "in kind" contributions from AIBL research partner organisations: University of Melbourne, Neurosciences Australia Ltd (NSA), Edith Cowan University (ECU), Mental Health Research Institute (MHRI), Alzheimer's Australia (AA), National Ageing Research Institute (NARI), Austin Health, University of WA (UWA), CogState Ltd., Macquarie University, Hollywood Private Hospital, and Sir Charles Gairdner Hospital. The funding source had no direct role in the design and conduct of the study; collection, management, analysis, and interpretation of the data, or preparation, review, and approval of the manuscript.